Tetraphase Pharmaceuticals Inc. (TTPH) Stock Price Down 1%
Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH)’s share price fell 1% during trading on Monday . The company traded as low as $3.85 and last traded at $3.91, with a volume of 167,006 shares traded. The stock had previously closed at $3.95.
A number of research firms have recently commented on TTPH. Needham & Company LLC reaffirmed a “hold” rating on shares of Tetraphase Pharmaceuticals in a report on Saturday, May 14th. Wedbush reaffirmed a “buy” rating on shares of Tetraphase Pharmaceuticals in a report on Saturday, May 14th. Gabelli lowered Tetraphase Pharmaceuticals from a “buy” rating to a “hold” rating and set a $7.00 price target for the company. in a report on Friday, May 13th. Finally, Zacks Investment Research raised Tetraphase Pharmaceuticals from a “hold” rating to a “buy” rating and set a $4.75 price target for the company in a report on Wednesday, July 6th. Twelve analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $14.85.
The firm’s market capitalization is $144.59 million. The stock’s 50 day moving average is $4.10 and its 200-day moving average is $4.38.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) last released its quarterly earnings data on Thursday, August 4th. The biopharmaceutical company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by $0.01. The company earned $1.20 million during the quarter, compared to analyst estimates of $2.05 million. The company’s quarterly revenue was down 63.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.72) earnings per share. On average, equities research analysts expect that Tetraphase Pharmaceuticals Inc. will post ($1.98) EPS for the current fiscal year.
A hedge fund recently raised its stake in Tetraphase Pharmaceuticals stock. California Public Employees Retirement System raised its stake in shares of Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) by 1,459.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 276,000 shares of the biopharmaceutical company’s stock after buying an additional 258,300 shares during the period. California Public Employees Retirement System owned approximately 0.76% of Tetraphase Pharmaceuticals worth $2,768,000 as of its most recent filing with the SEC.
Tetraphase Pharmaceuticals, Inc (Tetraphase) is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. It is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.